Trexquant Investment’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-71,107	Closed	-$610K	–	1511
2025 Q1	$610K	Sell	71,107 -367	-0.5%	-$3.47K	0.01%	1233
2024 Q4	$768K	Buy	71,474 +15,109	+27%	+$116K	0.01%	1180
2024 Q3	$320K	Buy	+56,365	New	+$325K	﹤0.01%	1338
2024 Q2	–	Sell	-83,185	Closed	-$423K	–	1510
2024 Q1	$423K	Buy	83,185 +25,530	+44%	+$144K	0.01%	1199
2023 Q4	$537K	Buy	+57,655	New	+$397K	0.01%	1058
2023 Q2	–	Sell	-59,695	Closed	-$512K	–	1430
2023 Q1	$512K	Sell	59,695 -123,418	-67%	-$1.23M	0.01%	988
2022 Q4	$1.7M	Buy	183,113 +166,363	+993%	+$1.78M	0.05%	468
2022 Q3	$173K	Sell	16,750 -13,271	-44%	-$140K	0.01%	1222
2022 Q2	$301K	Buy	+30,021	New	+$284K	0.01%	1114
2022 Q1	–	Sell	-13,601	Closed	-$236K	–	1345
2021 Q4	$236K	Sell	13,601 -1,654	-11%	-$31.4K	0.01%	1050
2021 Q3	$274K	Buy	+15,255	New	+$304K	0.02%	782